Camurus boosted investment sharply in the last year, with cash burn ramping by 57%. While that certainly give us pause, we take a lot of comfort in the strong annual revenue growth of 67%.

Camurus’s revenue didn’t grow at all in the last year. In fact, it fell 9.2%. That looks pretty grim, at a glance. Shareholders have seen the share price drop 32% in that time.

Camurus AB Annual stock financials by MarketWatch. View the latest CAMX financial statements, income statements and financial ratios.

Camurus is a Swedish science-led biopharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions.

Eli Lilly and Camurus have entered into partnership worth up to $870m to develop long-acting therapies in cardiometabolic health. The collaboration and licence agreement gives Lilly exclusive global ...

Camurus has operations across Europe, the US, and Australia, with headquarters in Lund, Sweden. The company's shares are listed on Nasdaq Stockholm under the ticker CAMX.

Under the agreement, Camurus will receive an upfront payment of $2 million and is eligible to receive up to $14.5 million in development milestones and other license payments, up to $55 million in ...

Camurus (NASDAQ STO: CAMX) and Braeburn Pharmaceuticals today announced positive top-line results from a long-term Phase 3 trial supporting the safety and efficacy of CAM2038 (weekly and monthly ...

Under the terms of the agreement, Camurus has granted Rhythm a worldwide license to the FluidCrystal technology to formulate setmelanotide and to develop, manufacture, and commercialize this new ...

Camurus already has institutions on the share registry. Indeed, they own 16% of the company. This implies the analysts working for those institutions have looked at the stock and they like it. But ...

Camurus announced today that Novartis has exercised its option to acquire an exclusive license for the further development and worldwide commercialization of CAM2029 for treatment of patients with ...

How Easily Can Camurus Raise Cash? Given the trajectory of Camurus's cash burn, many investors will already be thinking about how it might raise more cash in the future. Issuing new shares, or taking ...